The ASX has been trading flat at around 7,864 points.
Financials has been the best performing sector, up 0.3%, followed by Materials, up 0.15% and Energy, up 0.1%.
Utilities has been the worst performer, down 1.1%, followed by Industrials and Staples, both down 0.55%.
Opthea (ASX:OPT) has been the most watched on HotCopper forums today. The company is in a voluntary suspension pending the release of top line results of its COAST clinical trial.
Also trending Imugene (ASX:IMU) has revealed the US Food and Drug Administration has granted Fast Track Designation to its allogeneic CAR T-cell therapy, azer-cel (azercabtagene zapreleucel), for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL).
Rounding out the most discussed is Arizona Lithium (ASX:AZL) after kicking off a share purchase plan to raise $2 million to advance the Prairie project.
You’re up to date, see you later for market close.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.